DiA and Edan Instruments Collaborate to Offer AI-Based Cardiac Ultrasound Solutions

By MedImaging International staff writers
Posted on 10 Sep 2019

$Image: DiA Imaging Analysis has partnered with Edan Instruments to offer DiA\'s AI-based cardiac analysis solutions as an integrated part of Edan\'s ultrasound devices (Photo courtesy of DiA Imaging Analysis).$

Image: DiA Imaging Analysis has partnered with Edan Instruments to offer DiA\'s AI-based cardiac analysis solutions as an integrated part of Edan\'s ultrasound devices (Photo courtesy of DiA Imaging Analysis).

DiA Imaging Analysis Ltd. {(DiA) Be'er Sheva, Israel}, a provider of artificial intelligence (AI)-powered ultrasound analysis solutions, has entered into a partnership with Edan Instruments Inc. (Shenzen, China), a medical products and services company, to offer DiA's AI-based cardiac analysis solutions as an integrated part of Edan's ultrasound devices.

DiA uses advanced AI-based technology to assist clinicians at all levels of experience to acquire and analyze ultrasound images – objectively and accurately, improving patient management. DiA's solutions are cross-platform that can be easily implemented to ultrasound devices and healthcare IT systems, as an integrated part of clinician's workflow. DiA's AI-based cardiac solution, LVivo Toolbox, provides a fast and objective cardiac ultrasound analysis that assists in reducing the subjectivity and increasing the efficiency of clinician's decision-making process. LVivo Toolbox can be easily used by clinicians with various levels of experience and fits to operate as an integrated add-on solution on ultrasound devices and Healthcare IT systems.

Edan is a healthcare company engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. Edan has developed unique ultrasound devices that offer advanced imaging technologies, dual touch screens and a gesture-control user interface, supporting a wide range of clinical applications and delivering excellent image clarity.

"Edan provides innovative and high-quality medical products and services, bringing the most ground-breaking imaging technologies to its customers that best fit their clinical setting and needs," said Renfu Zhang, Edan's ultrasound product line director. "With DiA's AI-based cardiac solution, we will offer our customers an additional layer of automated AI-based analysis, as part of their everyday workflow."

"We are thrilled to partner with Edan Instruments and join forces to offer Edan's customers objective and fast clinical indications that they often struggle to find visually," said Hila Goldman Aslan, DiA's CEO and co-founder.

Related Links:
DiA Imaging Analysis
Edan Instruments

Visit expo >

Mobile X-Ray System

K4W

High-Precision QA Tool

DEXA Phantom

Digital Color Doppler Ultrasound System

MS22Plus

Breast Localization System

MAMMOREP LOOP

Latest Industry News News

Channels

Radiography

view channel

Images in a 75-year-old woman who underwent routine screening mammography in 2022. Left mediolateral oblique views shown from prior screening mammograms: (A) 2015, (B) 2018, (C) 2019, and (D) 2021. In (E) 2022, a new mass developed in the left breast at the 6-o’clock position (arrow), with a (F) corresponding irregular mass at US (arrow). Subsequent US-guided core needle biopsy yielded invasive ductal carcinoma, grade 2. The deep learning 5-year risk scores gradually increased from 2.0 (2015) to 2.1 (2018), 3.4 (2019), 3.6 (2021), and 15.3 (2022). CMFN = centimeters from nipple, LT = left, TRANS = transverse (Photo courtesy of Radiological Society of North America)

AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms

Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more

Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)

AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more

$Image: Kyushu University researchers use Dynamic Chest Radiography (DCR) to evaluate the severity of Pulmonary Regurgitation (PR), a common complication after treatment of the congenital heart disease Tetralogy of Fallot. The analysis only requires the patient to hold their breath for seven seconds for a sequence of images of their heart to be taken. The images are then analyzed and extracted into a waveform that can show the severity of PR. The new technique\\\'s detection accuracy of severe PR is 93%, with a sensitivity of 93% and a specificity of 94%. (Photo courtesty of Kyushu University/Yuzo Yamasaki)$

Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair

Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more

Image credit: Shu-Han Chen / St. Paul’s Hospital / National Taiwan University

AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays

Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read more

MRI

view channel

$Image: By training the AI with simulations, researchers can reconstruct brain images with high precision using only one-tenth of the data typically required in magnetic resonance imaging. The image shows a metric known as “fractional anisotropy”—an index of myelination—obtained using conventional methods and with the new approach (Photo courtesy of Instituto de Neurociencias UMH CSIC)$